Modalis Therapeutics Receivables

Modalis Therapeutics (4883.T) currently reports a receivables of $0 as of June 2026. That compares with $37M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Modalis Therapeutics's receivables history and peer comparisons.

Modalis Therapeutics's receivables decreased from $37M to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Modalis Therapeutics reported $0 in receivables as of June 2026. That compares with $37M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Modalis Therapeutics, and consider following 4883.T for alerts when major investors trade the stock.

Modalis Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4883.T with unrelated industries.